Journal of Nanobiotechnology, 2024 · DOI: https://doi.org/10.1186/s12951-024-02610-5 · Published: May 31, 2024
Spinal cord injury (SCI) often leads to motor and sensory deficits. Excessive reactive oxygen species (ROS) severely damage neurons in the early and middle stages of SCI. Most antioxidants can't consistently eliminate ROS at non-toxic doses, compromising treatment. Selenium nanoparticles (SeNPs) have excellent ROS scavenging bioactivity, but toxicity limits their use. This research proposes a synergistic therapeutic strategy using SeNPs encapsulated by ZIF-8 (SeNPs@ZIF-8) to boost ROS scavenging. Three different spatial structures of SeNPs@ZIF-8 were synthesized and coated with ferrostatin-1, a ferroptosis inhibitor (FSZ NPs), to enhance antioxidant and anti-ferroptosis activity without toxicity. FSZ NPs promoted the maintenance of mitochondrial homeostasis, regulating inflammatory factor expression and macrophage polarization into M2 phenotype. Additionally, they promoted neuronal maturation and axon growth by activating WNT4-dependent pathways, while preventing glial scar formation. This study demonstrates FSZ NPs' versatile bioactive functions for SCI treatment.
FSZ NPs offer a promising therapeutic strategy for SCI by addressing oxidative stress, inflammation, and promoting neural regeneration.
The use of biocompatible materials like GelMA hydrogel for local delivery of FSZ NPs enhances the translational potential for clinical applications.
The study provides insights into nanoparticle internalization mechanisms, which can inform the design of more effective drug delivery systems for neural injuries.